A global manufacturer of medical cannabis
Improving access to quality medicinal cannabis globally
Little Green Pharma is a leading global medicinal cannabis business with key production assets in Australia and Denmark (EU). Our primary goal is to improve patient access to GMP-grade cannabis medicines around the world. We do this by operating across the supply chain, from cultivation, manufacturing, distribution, and stakeholder engagement, allowing us to navigate barriers to access and provide our distributors, prescribers, and patients with a seamless end-to-end service for a broad range of cannabis medicines.
We are passionate about transforming lives for the better and making a world of difference to patients.
A pioneer in Australian medical cannabis
Little Green Pharma is a pioneer and innovator in Australian-grown, manufactured and exported Medicinal Cannabis for therapeutic use. We are a differentiated player in the rapidly expanding medical cannabis market and are driven by a strong belief that everybody deserves good health.
Bringing together nature and science, the company aims to provide targeted and natural therapeutic solutions that transform the lives of patients globally.
First locally-produced cannabis oil in Australia
Little Green Pharma was the first medicinal cannabis company in Australia to produce locally-grown medical-grade cannabis products for patients to access nationally.
Established in 2016 as a privately-owned company in Perth, Western Australia, we have been supplying Australian patients with medicinal cannabis products since August 2018 and stand proudly behind the green and gold Made in Australia label. Our Australian facility is located in the Southwest of WA and is currently producing 3 tonnes of dried biomass per annum which is then processed for both Australian and overseas markets (at June 2021).
World-class GMP-licensed facility in Denmark (EU)
Recognising the need for another facility to capitalise on our early mover status and brand recognition in Europe and Australia, Little Green Pharma acquired a world-class GMP-licensed medicinal cannabis cultivation and manufacturing facility in Denmark (EU). Comprising a 21,500 m2 cultivation site and 4,000 m2 post-harvest GMP manufacturing site, LGP’s Denmark Facility can produce in excess of 20 tonnes of biomass per annum including 12 tonnes per annum of GMP-manufactured cannabis flower for supply as bulk and finished medicinal cannabis flower products into global markets.